{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:47:12Z","timestamp":1787003232588,"version":"build-2736575974"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-65251-8","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:53:58Z","timestamp":1763556838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["C\u00a0&gt;\u00a0U mutations generate immunogenic peptides in SARS-CoV-2"],"prefix":"10.1038","volume":"16","author":[{"given":"Gerg\u0151 Mih\u00e1ly","family":"Balogh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Koncz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le\u00f3","family":"Asztalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Ari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolett","family":"G\u00e9mes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor J.","family":"Szebeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Tam\u00e1s","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7338-8231","authenticated-orcid":false,"given":"Franciska","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5187-9903","authenticated-orcid":false,"given":"Csaba","family":"P\u00e1l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0831-9617","authenticated-orcid":false,"given":"M\u00e1t\u00e9","family":"Manczinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"65251_CR1","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.cell.2021.01.037","volume":"184","author":"EC Thomson","year":"2021","unstructured":"Thomson, E. C. et al. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell 184, 1171\u20131187.e20 (2021).","journal-title":"Cell"},{"key":"65251_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41421-020-00226-1","volume":"6","author":"H Yao","year":"2020","unstructured":"Yao, H. et al. Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo. Cell Discov. 6, 76 (2020).","journal-title":"Cell Discov."},{"key":"65251_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41586-020-2895-3","volume":"592","author":"JA Plante","year":"2021","unstructured":"Plante, J. A. et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature 592, 116\u2013121 (2021).","journal-title":"Nature"},{"key":"65251_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","volume":"599","author":"P Mlcochova","year":"2021","unstructured":"Mlcochova, P. et al. SARS-CoV-2 B.1.617.2 delta variant replication and immune evasion. Nature 599, 114\u2013119 (2021).","journal-title":"Nature"},{"key":"65251_CR5","doi-asserted-by":"publisher","unstructured":"Agerer, B. et al. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8\u2009+\u2009T cell responses. Sci. Immunol. 6, https:\/\/doi.org\/10.1126\/sciimmunol.abg6461 (2021).","DOI":"10.1126\/sciimmunol.abg6461"},{"key":"65251_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34033-x","volume":"14","author":"OV Stanevich","year":"2023","unstructured":"Stanevich, O. V. et al. SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19. Nat. Commun. 14, 149 (2023).","journal-title":"Nat. Commun."},{"key":"65251_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cels.2021.09.013","volume":"13","author":"DJ Hamelin","year":"2022","unstructured":"Hamelin, D. J. et al. The mutational landscape of SARS-CoV-2 variants diversifies T cell targets in an HLA-supertype-dependent manner. Cell Syst. 13, 143\u2013157 (2022).","journal-title":"Cell Syst."},{"key":"65251_CR8","doi-asserted-by":"publisher","first-page":"105236","DOI":"10.1016\/j.meegid.2022.105236","volume":"99","author":"MAM Pretti","year":"2022","unstructured":"Pretti, M. A. M., Galvani, R. G., Scherer, N. M., Farias, A. S. & Boroni, M. In silico analysis of mutant epitopes in new SARS-CoV-2 lineages suggest global enhanced CD8\u2009+\u2009T cell reactivity and also signs of immune response escape. Infect. Genet. Evol. 99, 105236 (2022).","journal-title":"Infect. Genet. Evol."},{"key":"65251_CR9","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/genes11070761","volume":"11","author":"R Maty\u00e1\u0161ek","year":"2020","unstructured":"Maty\u00e1\u0161ek, R. & Kova\u0159\u00edk, A. Mutation patterns of human SARS-CoV-2 and bat RaTG13 coronavirus genomes are strongly biased towards C>U transitions, indicating rapid evolution in theirhosts. Genes 11, 761 (2020).","journal-title":"Genes"},{"key":"65251_CR10","doi-asserted-by":"publisher","first-page":"e00408","DOI":"10.1128\/mSphere.00408-20","volume":"5","author":"P Simmonds","year":"2020","unstructured":"Simmonds, P. Rampant C\u2192U hypermutation in the genomes of SARS-CoV-2 and other coronaviruses: causes and consequences for their short- and long-term evolutionary trajectories. mSphere 5, e00408\u2013e00420 (2020).","journal-title":"mSphere"},{"key":"65251_CR11","doi-asserted-by":"publisher","first-page":"eabb5813","DOI":"10.1126\/sciadv.abb5813","volume":"6","author":"S Di Giorgio","year":"2020","unstructured":"Di Giorgio, S., Martignano, F., Torcia, M. G., Mattiuz, G. & Conticello, S. G. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2. Sci. Adv. 6, eabb5813 (2020).","journal-title":"Sci. Adv."},{"key":"65251_CR12","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1093\/bioinformatics\/bty407","volume":"34","author":"J Hadfield","year":"2018","unstructured":"Hadfield, J. et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics 34, 4121\u20134123 (2018).","journal-title":"Bioinformatics"},{"key":"65251_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.chom.2021.02.017","volume":"29","author":"A Wu","year":"2021","unstructured":"Wu, A. et al. One year of SARS-CoV-2 evolution. Cell Host Microbe 29, 503\u2013507 (2021).","journal-title":"Cell Host Microbe"},{"key":"65251_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/molbev\/msaa188","volume":"38","author":"AM Rice","year":"2021","unstructured":"Rice, A. M. et al. Evidence for strong mutation Bias toward, and selection against, U content in SARS-CoV-2: implications for vaccine design. Mol. Biol. Evol. 38, 67\u201383 (2021).","journal-title":"Mol. Biol. Evol."},{"key":"65251_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/jmcb\/mjab011","volume":"13","author":"M Sadykov","year":"2021","unstructured":"Sadykov, M., Mourier, T., Guan, Q. & Pain, A. Short sequence motif dynamics in the SARS-CoV-2 genome suggest a role for cytosine deamination in CpG reduction. J. Mol. Cell Biol. 13, 225\u2013227 (2021).","journal-title":"J. Mol. Cell Biol."},{"key":"65251_CR16","doi-asserted-by":"publisher","first-page":"102116","DOI":"10.1016\/j.isci.2021.102116","volume":"24","author":"A Graudenzi","year":"2021","unstructured":"Graudenzi, A., Maspero, D., Angaroni, F., Piazza, R. & Ramazzotti, D. Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity. iScience 24, 102116 (2021).","journal-title":"iScience"},{"key":"65251_CR17","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","volume":"199","author":"V Jurtz","year":"2017","unstructured":"Jurtz, V. et al. NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data. J. Immunol. 199, 3360\u20133368 (2017).","journal-title":"J. Immunol."},{"key":"65251_CR18","doi-asserted-by":"crossref","unstructured":"Weiskopf, D. et al. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8 + T cells. Proc. Natl. Acad. Sci. USA. 110, E2046\u2013E2053 (2013).","DOI":"10.1073\/pnas.1305227110"},{"key":"65251_CR19","doi-asserted-by":"publisher","first-page":"e2100542118","DOI":"10.1073\/pnas.2100542118","volume":"118","author":"B Koncz","year":"2021","unstructured":"Koncz, B. et al. Self-mediated positive selection of T cells sets an obstacle to the recognition of nonself. Proc. Natl. Acad. Sci. USA 118, e2100542118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"65251_CR20","doi-asserted-by":"publisher","first-page":"vead055","DOI":"10.1093\/ve\/vead055","volume":"9","author":"JD Bloom","year":"2024","unstructured":"Bloom, J. D. & Neher, R. A. Fitness effects of mutations to SARS-CoV-2 proteins. Virus Evol. 9, vead055 (2024).","journal-title":"Virus Evol."},{"key":"65251_CR21","doi-asserted-by":"publisher","first-page":"1550341","DOI":"10.1080\/2162402X.2018.1550341","volume":"8","author":"A Boichard","year":"2019","unstructured":"Boichard, A. et al. APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy. OncoImmunology 8, 1550341 (2019).","journal-title":"OncoImmunology"},{"key":"65251_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","volume":"157","author":"J Kyte","year":"1982","unstructured":"Kyte, J. & Doolittle, R. F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105\u2013132 (1982).","journal-title":"J. Mol. Biol."},{"key":"65251_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-9-1","volume":"9","author":"J Sidney","year":"2008","unstructured":"Sidney, J., Peters, B., Frahm, N., Brander, C. & Sette, A. HLA class I supertypes: a revised and updated classification. BMC Immunol. 9, 1 (2008).","journal-title":"BMC Immunol."},{"key":"65251_CR24","doi-asserted-by":"publisher","first-page":"e0206512","DOI":"10.1371\/journal.pone.0206512","volume":"13","author":"L Abi-Rached","year":"2018","unstructured":"Abi-Rached, L. et al. Immune diversity sheds light on missing variation in worldwide genetic diversity panels. PLoS ONE 13, e0206512 (2018).","journal-title":"PLoS ONE"},{"key":"65251_CR25","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"65251_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2217\/fvl-2020-0066","volume":"15","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. The divergence between SARS-CoV-2 and RaTG13 might be overestimated due to the extensive RNA modification. Future Virol. 15, 341\u2013347 (2020).","journal-title":"Future Virol."},{"key":"65251_CR27","doi-asserted-by":"publisher","first-page":"D339","DOI":"10.1093\/nar\/gky1006","volume":"47","author":"R Vita","year":"2019","unstructured":"Vita, R. et al. The immune epitope database (IEDB): 2018 update. Nucleic Acids Res. 47, D339\u2013D343 (2019).","journal-title":"Nucleic Acids Res."},{"key":"65251_CR28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss, P. The T cell immune response against SARS-CoV-2. Nat. Immunol. 23, 186\u2013193 (2022).","journal-title":"Nat. Immunol."},{"key":"65251_CR29","doi-asserted-by":"publisher","first-page":"eabg5021","DOI":"10.1126\/sciimmunol.abg5021","volume":"6","author":"S Notarbartolo","year":"2021","unstructured":"Notarbartolo, S. et al. Integrated longitudinal immunophenotypic, transcriptional, and repertoire analyses delineate immune responses in patients with COVID-19. Sci. Immunol. 6, eabg5021 (2021).","journal-title":"Sci. Immunol."},{"key":"65251_CR30","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.immuni.2021.05.010","volume":"54","author":"L Bergamaschi","year":"2021","unstructured":"Bergamaschi, L. et al. Longitudinal analysis reveals that delayed bystander CD8\u2009+\u2009T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity 54, 1257\u20131275 (2021).","journal-title":"Immunity"},{"key":"65251_CR31","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","volume":"183","author":"C Rydyznski Moderbacher","year":"2020","unstructured":"Rydyznski Moderbacher, C. et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 183, 996\u20131012.e19 (2020).","journal-title":"Cell"},{"key":"65251_CR32","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","volume":"27","author":"EM Bange","year":"2021","unstructured":"Bange, E. M. et al. CD8\u2009+\u2009T cells contribute to survival in patients with COVID-19 and hematologic cancer. Nat. Med. 27, 1280\u20131289 (2021).","journal-title":"Nat. Med."},{"key":"65251_CR33","first-page":"e02243","volume":"11","author":"J Westmeier","year":"2020","unstructured":"Westmeier, J. et al. Impaired cytotoxic CD8 + T cell response in elderly COVID-19 patients. mBio 11, e02243\u201320 (2020).","journal-title":"mBio"},{"key":"65251_CR34","doi-asserted-by":"publisher","first-page":"1176168","DOI":"10.3389\/fmed.2023.1176168","volume":"10","author":"E Szab\u00f3","year":"2023","unstructured":"Szab\u00f3, E. et al. Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2. Front. Med. 10, 1176168 (2023).","journal-title":"Front. Med."},{"key":"65251_CR35","doi-asserted-by":"publisher","first-page":"2027160","DOI":"10.1080\/21645515.2022.2027160","volume":"18","author":"I Mohammed","year":"2022","unstructured":"Mohammed, I. et al. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review. Hum. Vaccin. Immunother. 18, 2027160 (2022).","journal-title":"Hum. Vaccin. Immunother."},{"key":"65251_CR36","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1002\/jmv.27609","volume":"94","author":"C Huang","year":"2022","unstructured":"Huang, C., Yang, L., Pan, J., Xu, X. & Peng, R. Correlation between vaccine coverage and the COVID-19 pandemic throughout the world: Based on real-world data. J. Med. Virol. 94, 2181\u20132187 (2022).","journal-title":"J. Med. Virol."},{"key":"65251_CR37","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.cell.2021.03.013","volume":"184","author":"WF Garcia-Beltran","year":"2021","unstructured":"Garcia-Beltran, W. F. et al. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell 184, 2372\u20132383 (2021).","journal-title":"Cell"},{"key":"65251_CR38","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1016\/j.cell.2021.02.037","volume":"184","author":"D Zhou","year":"2021","unstructured":"Zhou, D. et al. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera. Cell 184, 2348\u20132361 (2021).","journal-title":"Cell"},{"key":"65251_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41423-021-00836-z","volume":"19","author":"J Hu","year":"2022","unstructured":"Hu, J. et al. Increased immune escape of the new SARS-CoV-2 variant of concern Omicron. Cell Mol. Immunol. 19, 293\u2013295 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"65251_CR40","doi-asserted-by":"publisher","first-page":"109708","DOI":"10.1016\/j.celrep.2021.109708","volume":"36","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Profiling CD8\u2009+\u2009T cell epitopes of COVID-19 convalescents reveals reduced cellular immune responses to SARS-CoV-2 variants. Cell Rep. 36, 109708 (2021).","journal-title":"Cell Rep."},{"key":"65251_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19067-x","volume":"12","author":"K Kim","year":"2022","unstructured":"Kim, K. et al. The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness. Sci. Rep. 12, 14972 (2022).","journal-title":"Sci. Rep."},{"key":"65251_CR42","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/nar\/gkac1238","volume":"51","author":"Y Nakata","year":"2023","unstructured":"Nakata, Y. et al. Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome. Nucleic Acids Res. 51, 783\u2013795 (2023).","journal-title":"Nucleic Acids Res."},{"key":"65251_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.antiviral.2017.11.006","volume":"149","author":"Y Chen","year":"2018","unstructured":"Chen, Y. et al. APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription. Antivir. Res. 149, 16\u201325 (2018).","journal-title":"Antivir. Res."},{"key":"65251_CR44","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1126\/science.1092066","volume":"303","author":"P Turelli","year":"2004","unstructured":"Turelli, P., Mangeat, B., Jost, S., Vianin, S. & Trono, D. Inhibition of hepatitis B virus replication by APOBEC3G. Science 303, 1829\u20131829 (2004).","journal-title":"Science"},{"key":"65251_CR45","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1128\/JVI.02383-14","volume":"89","author":"CJ Warren","year":"2015","unstructured":"Warren, C. J. et al. APOBEC3A Functions as a restriction factor of human papillomavirus. J. Virol. 89, 688\u2013702 (2015).","journal-title":"J. Virol."},{"key":"65251_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14730-1","volume":"11","author":"B Zhu","year":"2020","unstructured":"Zhu, B. et al. Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance. Nat. Commun. 11, 886 (2020).","journal-title":"Nat. Commun."},{"key":"65251_CR47","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/v13030390","volume":"13","author":"AZ Cheng","year":"2021","unstructured":"Cheng, A. Z. et al. APOBECs and Herpesviruses. Viruses 13, 390 (2021).","journal-title":"Viruses"},{"key":"65251_CR48","doi-asserted-by":"publisher","first-page":"8005","DOI":"10.1128\/JVI.00973-16","volume":"90","author":"Y Nakaya","year":"2016","unstructured":"Nakaya, Y., Stavrou, S., Blouch, K., Tattersall, P. & Ross, S. R. In vivo examination of mouse APOBEC3- and human APOBEC3A- and APOBEC3G-mediated restriction of parvovirus and herpesvirus infection in mouse models. J. Virol. 90, 8005\u20138012 (2016).","journal-title":"J. Virol."},{"key":"65251_CR49","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.3389\/fimmu.2018.03032","volume":"9","author":"F Borzooee","year":"2019","unstructured":"Borzooee, F., Joris, K. D., Grant, M. D. & Larijani, M. APOBEC3G Regulation of the evolutionary race between adaptive immunity and viral immune escape is deeply imprinted in the HIV genome. Front. Immunol. 9, 3032 (2019).","journal-title":"Front. Immunol."},{"key":"65251_CR50","doi-asserted-by":"publisher","first-page":"e93428","DOI":"10.1371\/journal.pone.0093428","volume":"9","author":"M Monajemi","year":"2014","unstructured":"Monajemi, M. et al. Positioning of APOBEC3G\/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8\u2009+\u2009T Cells. PLoS ONE 9, e93428 (2014).","journal-title":"PLoS ONE"},{"key":"65251_CR51","doi-asserted-by":"publisher","first-page":"e1004281","DOI":"10.1371\/journal.ppat.1004281","volume":"10","author":"E-Y Kim","year":"2014","unstructured":"Kim, E.-Y. et al. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural Infection. PLoS Pathog. 10, e1004281 (2014).","journal-title":"PLoS Pathog."},{"key":"65251_CR52","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/QAI.0000000000000689","volume":"70","author":"KD Squires","year":"2015","unstructured":"Squires, K. D., Monajemi, M., Woodworth, C. F., Grant, M. D. & Larijani, M. Impact of APOBEC mutations on CD8\u2009+\u2009T cell recognition of HIV epitopes varies depending on the restricting HLA. JAIDS J. Acquir. Immune Defic. Syndr. 70, 172\u2013178 (2015).","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"65251_CR53","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/ni.2087","volume":"12","author":"JM Norman","year":"2011","unstructured":"Norman, J. M. et al. The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells. Nat. Immunol. 12, 975\u2013983 (2011).","journal-title":"Nat. Immunol."},{"key":"65251_CR54","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/s41564-024-01655-4","volume":"9","author":"CC Bradley","year":"2024","unstructured":"Bradley, C. C. et al. Targeted accurate RNA consensus sequencing (tARC-seq) reveals mechanisms of replication error affecting SARS-CoV-2 divergence. Nat. Microbiol. 9, 1382\u20131392 (2024).","journal-title":"Nat. Microbiol."},{"key":"65251_CR55","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41586-023-06331-x","volume":"620","author":"DG Augusto","year":"2023","unstructured":"Augusto, D. G. et al. A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection. Nature 620, 128\u2013136 (2023).","journal-title":"Nature"},{"key":"65251_CR56","doi-asserted-by":"publisher","first-page":"e20202617","DOI":"10.1084\/jem.20202617","volume":"218","author":"N Le Bert","year":"2021","unstructured":"Le Bert, N. et al. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection. J. Exp. Med. 218, e20202617 (2021).","journal-title":"J. Exp. Med."},{"key":"65251_CR57","doi-asserted-by":"publisher","first-page":"362","DOI":"10.7326\/M20-3012","volume":"173","author":"DP Oran","year":"2020","unstructured":"Oran, D. P. & Topol, E. J. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann. Intern. Med. 173, 362\u2013367 (2020).","journal-title":"Ann. Intern. Med."},{"key":"65251_CR58","doi-asserted-by":"publisher","first-page":"e2035057","DOI":"10.1001\/jamanetworkopen.2020.35057","volume":"4","author":"MA Johansson","year":"2021","unstructured":"Johansson, M. A. et al. SARS-CoV-2 Transmission from people without COVID-19 symptoms. JAMA Netw. Open 4, e2035057 (2021).","journal-title":"JAMA Netw. Open"},{"key":"65251_CR59","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1017\/S0950268822001467","volume":"150","author":"J Tan","year":"2022","unstructured":"Tan, J. et al. Transmission roles of symptomatic and asymptomatic COVID-19 cases: a modelling study. Epidemiol. Infect. 150, e171 (2022).","journal-title":"Epidemiol. Infect."},{"key":"65251_CR60","doi-asserted-by":"publisher","first-page":"e58699","DOI":"10.7554\/eLife.58699","volume":"9","author":"JC Emery","year":"2020","unstructured":"Emery, J. C. et al. The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship. ELife 9, e58699 (2020).","journal-title":"ELife"},{"key":"65251_CR61","doi-asserted-by":"publisher","first-page":"104351","DOI":"10.1016\/j.meegid.2020.104351","volume":"83","author":"L van Dorp","year":"2020","unstructured":"van Dorp, L. et al. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect. Genet. Evol. 83, 104351 (2020).","journal-title":"Infect. Genet. Evol."},{"key":"65251_CR62","doi-asserted-by":"crossref","unstructured":"Directional mutational pressure affects the amino acid composition and hydrophobicity of proteins in bacteria. in Contemporary Issues in Genetics and Evolution 383\u2013391 (Springer Netherlands, Dordrecht, 1998).","DOI":"10.1007\/978-94-011-5210-5_31"},{"key":"65251_CR63","doi-asserted-by":"publisher","first-page":"e1009596","DOI":"10.1371\/journal.ppat.1009596","volume":"17","author":"P Simmonds","year":"2021","unstructured":"Simmonds, P. & Ansari, M. A. Extensive C->U transition biases in the genomes of a wide range of mammalian RNA viruses; potential associations with transcriptional mutations, damage- or host-mediated editing of viral RNA. PLoS Pathog. 17, e1009596 (2021).","journal-title":"PLoS Pathog."},{"key":"65251_CR64","doi-asserted-by":"publisher","first-page":"e1006215","DOI":"10.1371\/journal.ppat.1006215","volume":"13","author":"JL Geoghegan","year":"2017","unstructured":"Geoghegan, J. L., Duch\u00eane, S. & Holmes, E. C. Comparative analysis estimates the relative frequencies of co-divergence and cross-species transmission within viral families. PLoS Pathog. 13, e1006215 (2017).","journal-title":"PLoS Pathog."},{"key":"65251_CR65","doi-asserted-by":"publisher","first-page":"s3","DOI":"10.1016\/S0966-842X(02)02428-9","volume":"10","author":"MEJ Woolhouse","year":"2002","unstructured":"Woolhouse, M. E. J. Population biology of emerging and re-emerging pathogens. Trends Microbiol. 10, s3\u2013s7 (2002).","journal-title":"Trends Microbiol."},{"key":"65251_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/srep14830","volume":"5","author":"C Kreuder Johnson","year":"2015","unstructured":"Kreuder Johnson, C. et al. Spillover and pandemic properties of zoonotic viruses with high host plasticity. Sci. Rep. 5, 14830 (2015).","journal-title":"Sci. Rep."},{"key":"65251_CR67","doi-asserted-by":"publisher","first-page":"20190575","DOI":"10.1098\/rstb.2019.0575","volume":"375","author":"D Enard","year":"2020","unstructured":"Enard, D. & Petrov, D. A. Ancient RNA virus epidemics through the lens of recent adaptation in human genomes. Philos. Trans. R. Soc. B 375, 20190575 (2020).","journal-title":"Philos. Trans. R. Soc. B"},{"key":"65251_CR68","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/emboj.2011.62","volume":"30","author":"L Huang","year":"2011","unstructured":"Huang, L., Kuhls, M. C. & Eisenlohr, L. C. Hydrophobicity as a driver of MHC class I antigen processing: Hydrophobicity in MHC class I peptide supply. EMBO J. 30, 1634\u20131644 (2011).","journal-title":"EMBO J."},{"key":"65251_CR69","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1111\/cas.14113","volume":"110","author":"H Chen","year":"2019","unstructured":"Chen, H. et al. The immune response-related mutational signatures and driver genes in non-small-cell lung cancer. Cancer Sci. 110, 2348\u20132356 (2019).","journal-title":"Cancer Sci."},{"key":"65251_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14568-7","volume":"11","author":"CB Driscoll","year":"2020","unstructured":"Driscoll, C. B. et al. APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy. Nat. Commun. 11, 790 (2020).","journal-title":"Nat. Commun."},{"key":"65251_CR71","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1158\/2326-6066.CIR-21-0146","volume":"10","author":"AV DiMarco","year":"2022","unstructured":"DiMarco, A. V. et al. APOBEC Mutagenesis inhibits breast cancer growth through induction of T cell\u2013mediated antitumor immune Responses. Cancer Immunol. Res. 10, 70\u201386 (2022).","journal-title":"Cancer Immunol. Res."},{"key":"65251_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/srep27702","volume":"6","author":"SA Mullane","year":"2016","unstructured":"Mullane, S. A. et al. Correlation of Apobec Mrna expression with overall survival and pd-l1 expression in urothelial carcinoma. Sci. Rep. 6, 27702 (2016).","journal-title":"Sci. Rep."},{"key":"65251_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12910","volume":"7","author":"M Smid","year":"2016","unstructured":"Smid, M. et al. Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration. Nat. Commun. 7, 12910 (2016).","journal-title":"Nat. Commun."},{"key":"65251_CR74","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1038\/s41388-018-0245-9","volume":"37","author":"S Wang","year":"2018","unstructured":"Wang, S., Jia, M., He, Z. & Liu, X.-S. APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer. Oncogene 37, 3924\u20133936 (2018).","journal-title":"Oncogene"},{"key":"65251_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-6-229","volume":"9","author":"SG Conticello","year":"2008","unstructured":"Conticello, S. G. The AID\/APOBEC family of nucleic acid mutators. Genome Biol. 9, 229 (2008).","journal-title":"Genome Biol."},{"key":"65251_CR76","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1126\/science.1229237","volume":"339","author":"MA O\u2019Leary","year":"2013","unstructured":"O\u2019Leary, M. A. et al. The placental mammal ancestor and the post\u2013K-Pg radiation of placentals. Science 339, 662\u2013667 (2013).","journal-title":"Science"},{"key":"65251_CR77","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11430-020-9608-x","volume":"63","author":"S Gong","year":"2020","unstructured":"Gong, S., Xie, H. & Chen, F. Spatiotemporal changes of epidemics and their relationship with human living environments in China over the past 2200 years. Sci. China Earth Sci. 63, 1223\u20131226 (2020).","journal-title":"Sci. China Earth Sci."},{"key":"65251_CR78","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1017\/S0950268809990136","volume":"137","author":"A Morabia","year":"2009","unstructured":"Morabia, A. Epidemic and population patterns in the Chinese Empire (243 b.c.e. to 1911 c.e.): quantitative analysis of a unique but neglected epidemic catalogue. Epidemiol. Infect. 137, 1361\u20131368 (2009).","journal-title":"Epidemiol. Infect."},{"key":"65251_CR79","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1016\/j.cub.2021.05.067","volume":"31","author":"Y Souilmi","year":"2021","unstructured":"Souilmi, Y. et al. An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia. Curr. Biol. 31, 3504\u20133514 (2021).","journal-title":"Curr. Biol."},{"key":"65251_CR80","doi-asserted-by":"publisher","unstructured":"Morris, S. C. et al. Natural selection exerted by historical coronavirus epidemic(s): comparative genetic analysis in China Kadoorie Biobank and UK Biobank. Preprint at https:\/\/doi.org\/10.1101\/2024.02.06.579075 (2024).","DOI":"10.1101\/2024.02.06.579075"},{"key":"65251_CR81","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","volume":"5","author":"R Ihaka","year":"1996","unstructured":"Ihaka, R. & Gentleman, R. R: A language for data analysis and graphics. J. Comput. Graph. Stat. 5, 299\u2013314 (1996).","journal-title":"J. Comput. Graph. Stat."},{"key":"65251_CR82","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/wics.147","volume":"3","author":"H Wickham","year":"2011","unstructured":"Wickham, H. ggplot2. WIREs Comput. Stats 3, 180\u2013185 (2011).","journal-title":"WIREs Comput. Stats"},{"key":"65251_CR83","unstructured":"Kassambara, A. Ggpubr: \u2018ggplot2\u2019 Based Publication Ready Plots. (2025)."},{"key":"65251_CR84","unstructured":"Gordon, M. & Lumley, T. Forestplot: Advanced Forest Plot Using \u2018grid\u2019 Graphics. (2025)."},{"key":"65251_CR85","unstructured":"Kolde, R. Pheatmap: Pretty Heatmaps. (2025)."},{"key":"65251_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 12, 77 (2011).","journal-title":"BMC Bioinform."},{"key":"65251_CR87","unstructured":"Wilke, C. O. Cowplot: Streamlined Plot Theme and Plot Annotations for \u2018Ggplot2\u2019. (2025)."},{"key":"65251_CR88","doi-asserted-by":"publisher","unstructured":"Ogle, D. H., Doll, J. C., Wheeler, A. P. & Dinno, A. FSA: simple fisheries stock assessment methods. https:\/\/doi.org\/10.32614\/CRAN.package.FSA (2015).","DOI":"10.32614\/CRAN.package.FSA"},{"key":"65251_CR89","doi-asserted-by":"crossref","unstructured":"Kuznetsova, A., Brockhoff, P. B. & Christensen, R. H. B. lmertest package: tests in linear mixed effects models. J. Stat. Soft. 82, 1\u201326 (2017).","DOI":"10.18637\/jss.v082.i13"},{"key":"65251_CR90","unstructured":"Solt, F. & Hu, Y. Dotwhisker: Dot-and-Whisker Plots of Regression Results. (2024)."},{"key":"65251_CR91","doi-asserted-by":"publisher","unstructured":"Bolker, B. & Robinson, D. broom.mixed: Tidying methods for mixed models. https:\/\/doi.org\/10.32614\/CRAN.package.broom.mixed (2018).","DOI":"10.32614\/CRAN.package.broom.mixed"},{"key":"65251_CR92","doi-asserted-by":"publisher","unstructured":"Kassambara, A. rstatix: Pipe-friendly framework for basic statistical tests. https:\/\/doi.org\/10.32614\/CRAN.package.rstatix (2019).","DOI":"10.32614\/CRAN.package.rstatix"},{"key":"65251_CR93","doi-asserted-by":"publisher","unstructured":"Pohlert, T. PMCMRplus: Calculate pairwise multiple comparisons ofmean rank sums extended. https:\/\/doi.org\/10.32614\/CRAN.package.PMCMRplus (2018).","DOI":"10.32614\/CRAN.package.PMCMRplus"},{"key":"65251_CR94","doi-asserted-by":"publisher","first-page":"e0237689","DOI":"10.1371\/journal.pone.0237689","volume":"15","author":"LJ Klimczak","year":"2020","unstructured":"Klimczak, L. J., Randall, T. A., Saini, N., Li, J.-L. & Gordenin, D. A. Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic. PLoS ONE 15, e0237689 (2020).","journal-title":"PLoS ONE"},{"key":"65251_CR95","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.cell.2017.09.050","volume":"171","author":"R Marty","year":"2017","unstructured":"Marty, R. et al. MHC-I Genotype restricts the oncogenic mutational landscape. Cell 171, 1272\u20131283 (2017).","journal-title":"Cell"},{"key":"65251_CR96","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to Multiple Testing. J. R. Stat. Soc. Ser. B Methodol. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"key":"65251_CR97","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41587-019-0322-9","volume":"38","author":"S Sarkizova","year":"2020","unstructured":"Sarkizova, S. et al. A large peptidome dataset improves HLA class I epitope prediction across most of the human population. Nat. Biotechnol. 38, 199\u2013209 (2020).","journal-title":"Nat. Biotechnol."},{"key":"65251_CR98","doi-asserted-by":"publisher","first-page":"7012","DOI":"10.21105\/joss.07012","volume":"9","author":"BJ-M Tremblay","year":"2024","unstructured":"Tremblay, B. J.-M. universalmotif: An R package for biological motifanalysis. JOSS 9, 7012 (2024).","journal-title":"JOSS"},{"key":"65251_CR99","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/bioinformatics\/btaa784","volume":"37","author":"DW Brown","year":"2021","unstructured":"Brown, D. W., Myers, T. A. & Machiela, M. J. PCAmatchR: a flexible R package for optimal case\u2013control matching using weighted principal components. Bioinformatics 37, 1178\u20131181 (2021).","journal-title":"Bioinformatics"},{"key":"65251_CR100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-19818-2","volume":"11","author":"L van Dorp","year":"2020","unstructured":"van Dorp, L. et al. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. Nat. Commun. 11, 1\u20138 (2020).","journal-title":"Nat. Commun."},{"key":"65251_CR101","doi-asserted-by":"publisher","first-page":"11411","DOI":"10.3390\/ijms231911411","volume":"23","author":"D Honfi","year":"2022","unstructured":"Honfi, D. et al. Comparison of homologous and heterologous booster SARS-CoV-2 vaccination in autoimmune rheumatic and musculoskeletal patients. IJMS 23, 11411 (2022).","journal-title":"IJMS"},{"key":"65251_CR102","doi-asserted-by":"publisher","first-page":"846248","DOI":"10.3389\/fimmu.2022.846248","volume":"13","author":"GJ Szebeni","year":"2022","unstructured":"Szebeni, G. J. et al. Humoral and cellular immunogenicity and safety of five different SARS-CoV-2 vaccines in patients with autoimmune rheumatic and musculoskeletal diseases in remission or with low disease activity and in healthy controls: a single center study. Front. Immunol. 13, 846248 (2022).","journal-title":"Front. Immunol."},{"key":"65251_CR103","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).","journal-title":"PLoS Med."},{"key":"65251_CR104","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10654-021-00722-y","volume":"36","author":"J Elliott","year":"2021","unstructured":"Elliott, J. et al. COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors. Eur. J. Epidemiol. 36, 299\u2013309 (2021).","journal-title":"Eur. J. Epidemiol."},{"key":"65251_CR105","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.mayocpiqo.2021.08.011","volume":"5","author":"AV Rowlands","year":"2021","unstructured":"Rowlands, A. V. et al. Association between accelerometer-assessed physical activity and severity of COVID-19 in UK Biobank. Mayo Clin. Proc. Innov. Qual. Outcomes 5, 997\u20131007 (2021).","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes"},{"key":"65251_CR106","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41562-021-01122-8","volume":"5","author":"E Mathieu","year":"2021","unstructured":"Mathieu, E. et al. A global database of COVID-19 vaccinations. Nat. Hum. Behav. 5, 947\u2013953 (2021).","journal-title":"Nat. Hum. Behav."},{"key":"65251_CR107","doi-asserted-by":"publisher","first-page":"e2378","DOI":"10.1002\/rmv.2378","volume":"33","author":"Z Dobrijevi\u0107","year":"2023","unstructured":"Dobrijevi\u0107, Z. et al. The association of human leucocyte antigen (HLA) alleles with COVID-19 severity: A systematic review and meta-analysis. Rev. Med. Virol. 33, e2378 (2023).","journal-title":"Rev. Med. Virol."},{"key":"65251_CR108","doi-asserted-by":"publisher","unstructured":"Balogh, G. et al. C\u2009>\u2009U mutations generate immunogenic peptides in SARS-CoV-2. Zenodo https:\/\/doi.org\/10.5281\/ZENODO.17019282 (2025).","DOI":"10.5281\/ZENODO.17019282"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65251-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65251-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65251-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:02:38Z","timestamp":1763560958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65251-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65251"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65251-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"8 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10156"}}